J. Lipid Res.  Neurobiology of Lipids (ISSN1683-5506)
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rensen, P. C.
Right arrow Articles by van Berkel, T. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rensen, P. C.
Right arrow Articles by van Berkel, T. J.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Journal of Lipid Research, Vol 38, 1070-1084, Copyright © 1997 by Lipid Research, Inc.


ARTICLES

Particle size determines the specificity of apolipoprotein E-containing triglyceride-rich emulsions for the LDL receptor versus hepatic remnant receptor in vivo

PC Rensen, N Herijgers, MH Netscher, SC Meskers, M van Eck and TJ van Berkel
Division of Biopharmaceutics, Leiden-Amsterdam Center for Drug Research, University of Leiden, Sylvius Laboratories, The Netherlands.

Apolipoprotein E (apoE) is an important determinant for the uptake of triglyceride-rich emulsions and lipoproteins by the liver, and exerts affinity for both the LDL receptor (LDLr) and a distinct liver-specific recognition site. Our current aim was to assess the mechanism underlying the receptor-specificity of apoE-carrying lipoproteins. Triglyceride-rich emulsions were synthesized, with mean sizes of 50, 80, and 150 nm. These fractions efficiently acquired apoE from rat serum, and were processed by LPL in vivo with a similar efficiency. Upon injection of the [5H]cholesteryl oleate-labeled emulsions into rats, the liver association rate was positively correlated with particle size (24 +/- 2%, 54 +/- 1%, and 64 +/- 3% of the injected dose at 20 min after injection, respectively) and the liver uptake was predominantly exerted by parenchymal cells. The role of the LDLr in emulsion clearance was established in wild-type versus LDLr knockout mice. In the absence of the LDLr, an 8-fold increased serum half-life was observed for the small emulsion, concomitant with a 6- and 15-fold decreased uptake by the liver and adrenals at 60 min after injection, respectively. In contrast, the in vivo behavior of the large emulsion was independent of the LDLr. Both the ratio of apoE:C on the emulsions upon serum incubation and the alpha-helical content of apoE were inversely correlated with particle size, indicating that these factors may be involved in the emulsion size-dependent receptor specificity in vivo. It is concluded that the contribution of the LDLr to the apoE- mediated clearance of emulsions by the liver and adrenals strongly increases with decreasing particle size, while large particles initially associate with a distinct liver-specific recognition site. As these emulsions mimic chylomicrons, we anticipate that the apoE- dependent metabolic behavior of chylomicrons (remnants) is largely dependent on their size.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Lipid Res.Home page
L. Hu, C. C. van der Hoogt, S. M. S. Espirito Santo, R. Out, K. E. Kypreos, B. J. M. van Vlijmen, T. J. C. Van Berkel, J. A. Romijn, L. M. Havekes, K. W. van Dijk, et al.
The hepatic uptake of VLDL in lrp-ldlr-/-vldlr-/- mice is regulated by LPL activity and involves proteoglycans and SR-BI
J. Lipid Res., July 1, 2008; 49(7): 1553 - 1561.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
L. Lichtenstein, J. F.P. Berbee, S. J. van Dijk, K. W. van Dijk, A. Bensadoun, I. P. Kema, P. J. Voshol, M. Muller, P. C.N. Rensen, and S. Kersten
Angptl4 Upregulates Cholesterol Synthesis in Liver via Inhibition of LPL- and HL-Dependent Hepatic Cholesterol Uptake
Arterioscler. Thromb. Vasc. Biol., November 1, 2007; 27(11): 2420 - 2427.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
C. J. A. Moen, A. P. Tholens, P. J. Voshol, W. de Haan, L. M. Havekes, P. Gargalovic, A. J. Lusis, K. W. van Dyk, R. R. Frants, M. H. Hofker, et al.
The Hyplip2 locus causes hypertriglyceridemia by decreased clearance of triglycerides
J. Lipid Res., October 1, 2007; 48(10): 2182 - 2192.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
M. Westerterp, J. F. P. Berbee, D. J. M. Delsing, M. C. Jong, M. J. J. Gijbels, V. E. H. Dahlmans, E. H. Offerman, J. A. Romijn, L. M. Havekes, and P. C. N. Rensen
Apolipoprotein C-I binds free fatty acids and reduces their intracellular esterification
J. Lipid Res., June 1, 2007; 48(6): 1353 - 1361.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
K. Yasunaga, S. Saito, Y.-L. Zhang, A. Hernandez-Ono, and H. N. Ginsberg
Effects of triacylglycerol and diacylglycerol oils on blood clearance, tissue uptake, and hepatic apolipoprotein B secretion in mice
J. Lipid Res., May 1, 2007; 48(5): 1108 - 1121.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
S. M. Post, M. Groenendijk, C. C. van der Hoogt, C. Fievet, G. Luc, M. Hoekstra, H. M.G. Princen, B. Staels, and P. C.N. Rensen
Cholesterol 7{alpha}-Hydroxylase Deficiency in Mice on an APOE*3-Leiden Background Increases Hepatic ABCA1 mRNA Expression and HDL-Cholesterol
Arterioscler. Thromb. Vasc. Biol., December 1, 2006; 26(12): 2724 - 2730.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
K. Qi, T. Seo, Z. Jiang, Y. A. Carpentier, and R. J. Deckelbaum
Triglycerides in Fish Oil Affect the Blood Clearance of Lipid Emulsions Containing Long- and Medium-Chain Triglycerides in Mice
J. Nutr., November 1, 2006; 136(11): 2766 - 2772.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
J. F. P. Berbee, C. C. van der Hoogt, R. Kleemann, E. F. Schippers, R. L. Kitchens, J. T. van Dissel, I. A. J. M. Bakker-Woudenberg, L. M. Havekes, and P. C. N. Rensen
Apolipoprotein CI stimulates the response to lipopolysaccharide and reduces mortality in Gram-negative sepsis
FASEB J, October 1, 2006; 20(12): 2162 - 2164.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
I. Duivenvoorden, P. J Voshol, P. C. Rensen, W. van Duyvenvoorde, J. A Romijn, J. J Emeis, L. M Havekes, and W. F Nieuwenhuizen
Dietary sphingolipids lower plasma cholesterol and triacylglycerol and prevent liver steatosis in APOE*3Leiden mice.
Am. J. Clinical Nutrition, August 1, 2006; 84(2): 312 - 321.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
M. Westerterp, W. de Haan, J. F. P. Berbee, L. M. Havekes, and P. C. N. Rensen
Endogenous apoC-I increases hyperlipidemia in apoE-knockout mice by stimulating VLDL production and inhibiting LPL
J. Lipid Res., June 1, 2006; 47(6): 1203 - 1211.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
P. C.N. Rensen, L. A.J.M. Sliedregt, P. J. van Santbrink, M. Ferns, H. N.J. Schifferstein, S. H. van Leeuwen, J. H.M. Souverijn, T. J.C. van Berkel, and E. A.L. Biessen
Stimulation of Liver-Directed Cholesterol Flux in Mice by Novel N-Acetylgalactosamine-Terminated Glycolipids With High Affinity for the Asialoglycoprotein Receptor
Arterioscler. Thromb. Vasc. Biol., January 1, 2006; 26(1): 169 - 175.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. A.M. den Boer, J. F.P. Berbee, P. Reiss, M. van der Valk, P. J. Voshol, F. Kuipers, L. M. Havekes, P. C.N. Rensen, and J. A. Romijn
Ritonavir Impairs Lipoprotein Lipase-Mediated Lipolysis and Decreases Uptake of Fatty Acids in Adipose Tissue
Arterioscler. Thromb. Vasc. Biol., January 1, 2006; 26(1): 124 - 129.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
I. Grosskopf, N. Baroukh, S.-J. Lee, Y. Kamari, D. Harats, E. M. Rubin, L. A. Pennacchio, and A. D. Cooper
Apolipoprotein A-V Deficiency Results in Marked Hypertriglyceridemia Attributable to Decreased Lipolysis of Triglyceride-Rich Lipoproteins and Removal of Their Remnants
Arterioscler. Thromb. Vasc. Biol., December 1, 2005; 25(12): 2573 - 2579.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
J. R. Goudriaan, M. A. M. den Boer, P. C. N. Rensen, M. Febbraio, F. Kuipers, J. A. Romijn, L. M. Havekes, and P. J. Voshol
CD36 deficiency in mice impairs lipoprotein lipase-mediated triglyceride clearance
J. Lipid Res., October 1, 2005; 46(10): 2175 - 2181.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
G. Gerritsen, P. C. N. Rensen, K. E. Kypreos, V. I. Zannis, L. M. Havekes, and K. Willems van Dijk
ApoC-III deficiency prevents hyperlipidemia induced by apoE overexpression
J. Lipid Res., July 1, 2005; 46(7): 1466 - 1473.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
A. Werner, R. Havinga, T. Bos, V. W. Bloks, F. Kuipers, and H. J. Verkade
Essential fatty acid deficiency in mice is associated with hepatic steatosis and secretion of large VLDL particles
Am J Physiol Gastrointest Liver Physiol, June 1, 2005; 288(6): G1150 - G1158.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
I. Duivenvoorden, B. Teusink, P. C. Rensen, J. A. Romijn, L. M. Havekes, and P. J. Voshol
Apolipoprotein C3 Deficiency Results in Diet-Induced Obesity and Aggravated Insulin Resistance in Mice
Diabetes, March 1, 2005; 54(3): 664 - 671.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
J. F. P. Berbee, C. C. van der Hoogt, D. Sundararaman, L. M. Havekes, and P. C. N. Rensen
Severe hypertriglyceridemia in human APOC1 transgenic mice is caused by apoC-I-induced inhibition of LPL
J. Lipid Res., February 1, 2005; 46(2): 297 - 306.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
E.-M. Kim, H.-J. Jeong, I.-K. Park, C.-S. Cho, C.-G. Kim, and H.-S. Bom
Hepatocyte-Targeted Nuclear Imaging Using 99mTc-Galactosylated Chitosan: Conjugation, Targeting, and Biodistribution
J. Nucl. Med., January 1, 2005; 46(1): 141 - 145.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
C. Verseyden, S. Meijssen, and M. C. Cabezas
Effects of Atorvastatin on Fasting Plasma and Marginated Apolipoproteins B48 and B100 in Large, Triglyceride-Rich Lipoproteins in Familial Combined Hyperlipidemia
J. Clin. Endocrinol. Metab., October 1, 2004; 89(10): 5021 - 5029.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
J. R. Goudriaan, S. M. S. E. Santo, P. J. Voshol, B. Teusink, K. W. van Dijk, B. J. M. van Vlijmen, J. A. Romijn, L. M. Havekes, and P. C. N. Rensen
The VLDL receptor plays a major role in chylomicron metabolism by enhancing LPL-mediated triglyceride hydrolysis
J. Lipid Res., August 1, 2004; 45(8): 1475 - 1481.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
F. G. Schaap, P. C. N. Rensen, P. J. Voshol, C. Vrins, H. N. van der Vliet, R. A. F. M. Chamuleau, L. M. Havekes, A. K. Groen, and K. W. van Dijk
ApoAV Reduces Plasma Triglycerides by Inhibiting Very Low Density Lipoprotein-Triglyceride (VLDL-TG) Production and Stimulating Lipoprotein Lipase-mediated VLDL-TG Hydrolysis
J. Biol. Chem., July 2, 2004; 279(27): 27941 - 27947.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. Out, J. K. Kruijt, P. C. N. Rensen, R. B. Hildebrand, P. de Vos, M. Van Eck, and T. J. C. Van Berkel
Scavenger Receptor BI Plays a Role in Facilitating Chylomicron Metabolism
J. Biol. Chem., April 30, 2004; 279(18): 18401 - 18406.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
J. R. Goudriaan, V. E. H. Dahlmans, B. Teusink, D. M. Ouwens, M. Febbraio, J. A. Maassen, J. A. Romijn, L. M. Havekes, and P. J. Voshol
CD36 deficiency increases insulin sensitivity in muscle, but induces insulin resistance in the liver in mice
J. Lipid Res., December 1, 2003; 44(12): 2270 - 2277.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
B. Teusink, P. J. Voshol, V. E.H. Dahlmans, P. C.N. Rensen, H. Pijl, J. A. Romijn, and L. M. Havekes
Contribution of Fatty Acids Released From Lipolysis of Plasma Triglycerides to Total Plasma Fatty Acid Flux and Tissue-Specific Fatty Acid Uptake
Diabetes, March 1, 2003; 52(3): 614 - 620.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
G. Gerritsen, K. E. Kypreos, A. van der Zee, B. Teusink, V. I. Zannis, L. M. Havekes, and K. W. van Dijk
Hyperlipidemia in APOE2 transgenic mice is ameliorated by a truncated apoE variant lacking the C-terminal domain
J. Lipid Res., February 1, 2003; 44(2): 408 - 414.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
K. M. Yli-Jokipii, U. S. Schwab, R. L. Tahvonen, J.-P. Kurvinen, H. M. Mykkanen, and H. P. T. Kallio
Triacylglycerol Molecular Weight and to a Lesser Extent, Fatty Acid Positional Distribution, Affect Chylomicron Triacylglycerol Composition in Women
J. Nutr., May 1, 2002; 132(5): 924 - 929.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
M. C. Jong, P. C. N. Rensen, V. E. H. Dahlmans, H. van der Boom, T. J. C. van Berkel, and L. M. Havekes
Apolipoprotein C-III deficiency accelerates triglyceride hydrolysis by lipoprotein lipase in wild-type and apoE knockout mice
J. Lipid Res., October 1, 2001; 42(10): 1578 - 1585.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
H. Relas, H. Gylling, and T. A. Miettinen
Fate of intravenously administered squalene and plant sterols in human subjects
J. Lipid Res., June 1, 2001; 42(6): 988 - 994.
[Abstract] [Full Text]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
Th. B. Twickler, G. M. Dallinga-Thie, H. W. de Valk, P. C. N. J. Schreuder, H. Jansen, M. C. Cabezas, and D. W. Erkelens
High Dose of Simvastatin Normalizes Postprandial Remnant-Like Particle Response in Patients With Heterozygous Familial Hypercholesterolemia
Arterioscler. Thromb. Vasc. Biol., November 1, 2000; 20(11): 2422 - 2427.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. C. N. Rensen, M. C. Jong, L. C. van Vark, H. van der Boom, W. L. Hendriks, T. J. C. van Berkel, E. A. L. Biessen, and L. M. Havekes
Apolipoprotein E Is Resistant to Intracellular Degradation in Vitro and in Vivo. EVIDENCE FOR RETROENDOCYTOSIS
J. Biol. Chem., March 17, 2000; 275(12): 8564 - 8571.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
E. D. Breyer, N.-A. Le, X. Li, D. Martinson, and W. V. Brown
Apolipoprotein C-III displacement of apolipoprotein E from VLDL: effect of particle size
J. Lipid Res., October 1, 1999; 40(10): 1875 - 1882.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
A. J. Versluis, E. T. Rump, P. C. N. Rensen, T. J. C. van Berkel, and M. K. Bijsterbosch
Stable Incorporation of a Lipophilic Daunorubicin Prodrug into Apolipoprotein E-Exposing Liposomes Induces Uptake of Prodrug via Low-Density Lipoprotein Receptor in Vivo
J. Pharmacol. Exp. Ther., April 1, 1999; 289(1): 1 - 7.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
H. E. de Vries, A. C. E. Moor, T. M.A.R. Dubbelman, T. J. C. van Berkel, and J. Kuiper
Oxidized Low-Density Lipoprotein as a Delivery System for Photosensitizers: Implications for Photodynamic Therapy of Atherosclerosis
J. Pharmacol. Exp. Ther., April 1, 1999; 289(1): 528 - 534.
[Abstract] [Full Text]


Home page
J. Lipid Res.Home page
K. W. van Dijk, B. J. M. van Vlijmen, H. B. van't Hof, A. van der Zee, S. Santamarina-Fojo, T. J.C. van Berkel, L. M. Havekes, and M. H. Hofker
In LDL receptor-deficient mice, catabolism of remnant lipoproteins requires a high level of apoE but is inhibited by excess apoE
J. Lipid Res., February 1, 1999; 40(2): 336 - 344.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
N. Mekki, M. A. Christofilis, M. Charbonnier, C. Atlan-Gepner, C. Defoort, C. Juhel, P. Borel, H. Portugal, A. M. Pauli, B. Vialettes, et al.
Influence of Obesity and Body Fat Distribution on Postprandial Lipemia and Triglyceride-Rich Lipoproteins in Adult Women
J. Clin. Endocrinol. Metab., January 1, 1999; 84(1): 184 - 191.
[Abstract] [Full Text]


Home page
Mol. Pharmacol.Home page
P. C. N. Rensen, R. M. Schiffelers, A. J. Versluis, M. K. Bijsterbosch, M. E. M. J. Van Kuijk-Meuwissen, and T. J. C. Van Berkel
Human Recombinant Apolipoprotein E-Enriched Liposomes Can Mimic Low-Density Lipoproteins as Carriers for the Site-Specific Delivery of Antitumor Agents
Mol. Pharmacol., September 1, 1997; 52(3): 445 - 455.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
P. C. N. Rensen, L. A. J. M. Sliedregt, M. Ferns, E. Kieviet, S. M. W. van Rossenberg, S. H. van Leeuwen, T. J. C. van Berkel, and E. A. L. Biessen
Determination of the Upper Size Limit for Uptake and Processing of Ligands by the Asialoglycoprotein Receptor on Hepatocytes in Vitro and in Vivo
J. Biol. Chem., September 28, 2001; 276(40): 37577 - 37584.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Journal of Biological Chemistry 
 Molecular and Cellular Proteomics   ASBMB Today 
Copyright © 1997 by the American Society for Biochemistry and Molecular Biology.